Sudbury company attracts $8M investment to support its leading-edge cancer treatment technology
A Sudbury-based company has received $8 million in private investment to support its work in cancer diagnostic technology.
Rna Diagnostics grew out of work done at Laurentian University and Health Sciences North Research Institute (HSNRI). Dr. Amadeo Parissenti, a scientist and LU professor, has developed technology that allows doctors to tell whether chemotherapy is having an impact on a patient's cancer.
"The RNA disruption assay (RDA), patented by Laurentian University and licensed to Rna Diagnostics in 2010, determines whether a patient is responding to cancer therapy, early during treatment," the company said in a news release Wednesday.
Using RDA, doctors can determine within five weeks of the start of treatment whether chemotherapy is working, allowing doctors to tailor the treatment according to the individual patient's response.
"This means that if a patient’s tumour is not responding to treatment, 80 per cent of ineffective doses and lost time can be avoided," the company said.
Rna Diagnostics has received $8 million in what's known as 'series A' financing from iGan Partners and BDC Capital. Series A financing is private funding that startup companies receive when their product or service shows enough promise to attract investment.
The discovery of RDA was made in 2007 by Parissenti and his research associate, Dr. Baoqing Guo, in their lab at HSNRI. It was patented by Laurentian University in 2010.
Rna Diagnostics’ laboratory is headquartered at HSNRI in Sudbury.
“The continued support of iGan Partners and our current investors, combined with the support of BDC Capital as a new investment partner, is exciting,” John Connolly, president and CEO of Rna Diagnostics, said in the news release.
“The closing of this series A financing will allow us to complete the pivotal validation trial (BREVITY) of the RNA Disruption Assay. BREVITY is currently recruiting patients at over 40 breast cancer centres in Europe and North America.”
Parissenti continues to study the cellular mechanisms involved in RNA disruption with Dr. Carita Lanner and Dr. Tom Kovala of the Northern Ontario School of Medicine in the hopes of finding additional tools to predict or monitor chemotherapy response and outcome in cancer patients.
“Laurentian University is proud to offer its congratulations to Dr. Parissenti and Rna Diagnostics Inc. on this incredible milestone, the investment will provide critical funding to complete the clinical trials and bring to market a technology that will improve cancer treatments worldwide while impacting positively on the quality of life of cancer patients,” Tammy Eger, Laurentian University’s vice-president, research, said in the release.
“A true northern innovation created by outstanding partnerships and collaboration.”
“This is an enormous, expensive problem for cancer centres. Typically, in solid tumors, only 30-40 per cent of patients receive a survival benefit from a given drug regimen,” Connolly added. “Patients with nonresponsive tumours (identified by the RDA) can therefore forgo the ineffective treatment and its side-effects and moved quickly to alternate treatments.”
CTVNews.ca Top Stories
Canadian gov't proposes new foreign influence registry as part of wide-spanning new bill
Prime Minister Justin Trudeau's government is proposing a suite of new measures and law changes aimed at countering foreign interference in Canada, amid extensive scrutiny over past meddling attempts and an ever-evolving threat landscape.
Boeing Starliner capsule's first crewed test flight postponed
The long-awaited first crewed test flight of Boeing's new Starliner space capsule was called off for at least 24 hours over a technical issue that launch teams were unable to resolve in time for the planned Monday night lift-off.
Teacher charged in historical sexual assault of Calgary teenage girl
Calgary police have charged a teacher with the alleged sexual assault of a teenage girl more than 20 years ago.
Winnipeg man admits to killing four women, argues he's not criminally responsible
Defence lawyers of Jeremy Skibicki have admitted in court the accused killed four Indigenous women, but argues he is not criminally responsible for the deaths by way of mental disorder – this latest development has triggered a judge-alone trial rather than a jury trial.
Man banned from owning animals after fatal Calgary dog attack
The owner of three Calgary dogs that got loose and mauled a woman to death in 2022 has been ordered to pay a $15,000 fine within one year and banned from owning any animal for 15 years.
East-end Ottawa family dealing with massive rat infestation
Residents in Ottawa’s Elmridge Gardens complex are dealing with a rat infestation that just won’t go away. Now, after doing everything they can to try to fix the issue, they are pleading with the city to step in and help.
Mediterranean staple may lower your risk of death from dementia, study finds
A daily spoonful of olive oil could lower your risk of dying from dementia, according to a new study by Harvard scientists.
An El Nino-less summer is coming. Here's what that could mean for Canada
As Canadians brace themselves for summer temperatures, forecasters say a weakening El Nino cycle doesn’t mean relief from the heat.
Newfoundland and Labrador latest province to tighten rules on Airbnbs
Newfoundland and Labrador is the latest jurisdiction to bring in stricter rules for short-term rentals, with a coming set of regulations that will force operators to register with the provincial government.